A Randomized Phase II Study of Lenvatinib Versus Doxorubicin in Second Line Advanced or Recurrent Endometrial Carcinoma
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Lenvatinib (Primary) ; Doxorubicin
- Indications Endometrial cancer
- Focus Therapeutic Use
- 02 Jan 2017 New trial record